These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 26719941)

  • 1. Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors.
    Paula SB; Morey AT; Santos JP; Santos PM; Gameiro DG; Kerbauy G; Sena EM; Ueda LT; Carneiro M; Pinge-Filho P; Yamauchi LM; Yamada-Ogatta SF
    J Infect Dev Ctries; 2015 Dec; 9(12):1350-9. PubMed ID: 26719941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral colonization by Candida species in HIV-positive patients: association and antifungal susceptibility study.
    Goulart LS; Souza WWR; Vieira CA; Lima JS; Olinda RA; Araújo C
    Einstein (Sao Paulo); 2018 Aug; 16(3):eAO4224. PubMed ID: 30088546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
    Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
    J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predisposing factors for oropharyngeal colonization of yeasts in human immunodeficiency virus-infected patients: a prospective cross-sectional study.
    Lin JN; Lin CC; Lai CH; Yang YL; Chen HT; Weng HC; Hsieh LY; Kuo YC; Lauderdale TL; Tseng FC; Lin HH; Lo HJ
    J Microbiol Immunol Infect; 2013 Apr; 46(2):129-35. PubMed ID: 22921200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China.
    Li YY; Chen WY; Li X; Li HB; Li HQ; Wang L; He L; Yang XP; Wang XC; Huang YL; Yao YG
    BMC Infect Dis; 2013 Jan; 13():46. PubMed ID: 23356471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species.
    Hung CC; Yang YL; Lauderdale TL; McDonald LC; Hsiao CF; Cheng HH; Ho YA; Lo HJ
    J Clin Microbiol; 2005 Apr; 43(4):1600-3. PubMed ID: 15814972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon.
    Ambe NF; Longdoh NA; Tebid P; Bobga TP; Nkfusai CN; Ngwa SB; Nsai FS; Cumber SN
    Pan Afr Med J; 2020; 36():23. PubMed ID: 32774600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization.
    Delgado AC; de Jesus Pedro R; Aoki FH; Resende MR; Trabasso P; Colombo AL; de Oliveira MS; Mikami Y; Moretti ML
    Clin Microbiol Infect; 2009 Apr; 15(4):364-71. PubMed ID: 19431223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.
    Costa CR; de Lemos JA; Passos XS; de Araújo CR; Cohen AJ; Souza LK; Silva Mdo R
    Mycopathologia; 2006 Jul; 162(1):45-50. PubMed ID: 16830191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida species diversity and antifungal susceptibility patterns in oral samples of HIV/AIDS patients in Baja California, Mexico.
    Clark-Ordóñez I; Callejas-Negrete OA; Aréchiga-Carvajal ET; Mouriño-Pérez RR
    Med Mycol; 2017 Apr; 55(3):285-294. PubMed ID: 27630251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral candidiasis of HIV-infected children undergoing sequential HIV therapies.
    Melo NR; Taguchi H; Culhari VP; Kamei K; Mikami Y; Smith SN; Vilela MS
    Med Mycol; 2009 Mar; 47(2):149-56. PubMed ID: 18651304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
    Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
    Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia.
    Mulu A; Kassu A; Anagaw B; Moges B; Gelaw A; Alemayehu M; Belyhun Y; Biadglegne F; Hurissa Z; Moges F; Isogai E
    BMC Infect Dis; 2013 Feb; 13():82. PubMed ID: 23398783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
    Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibility of oral isolates of Candida species from chronic kidney disease patients on chronic dialysis.
    de la Rosa-García E; Olalde-Hernández MJ; Irigoyen-Camacho ME; Mondragón-Padilla A; Mendoza-Juache A; Sánchez-Vargas LO
    J Mycol Med; 2020 Sep; 30(3):101009. PubMed ID: 32620497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.